Fig. 4From: Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management programMean reduction in cost per patient after 6 months on study versus 6 months before baseline; PMP participants vs. non-participants. a Mean reduction in total cost per patient from societal perspective (281 patients with cost data available for visits 1 and 3). b Mean reduction in cost per patient from payers’ perspective (345 patients with cost data available for visits 1 and 3)Back to article page